News · Press release
Notice of a ceremonial decommissioning: Dissolution Chamber No. I
Furnetics Unlimited Ltd. today marked the ceremonial decommissioning of Dissolution Chamber No. I, the last of the corporation's first-generation Phenotype Renovations™ partial-organic dissolution chambers still on the standing inventory, at a closed observance held on the eleventh of November at the Sükhbaatar Square campus. The chamber, a single-column borosilicate glass cylinder of Cambridge manufacture engraved at the base with the initials of its principal designer, will be conveyed under permanent loan to the Whipple Museum of the History of Science at the University of Cambridge, with transport to Cambridge scheduled for the first quarter of 2020.
Chamber No. I was commissioned in the autumn of 1994 for the Hephaestus Group's preclinical dissolution-and-reconstruction programme at the Cambridge laboratory, and is the earliest surviving apparatus of what is now, in Group nomenclature, the “v1” Phenotype architecture — the direct antecedent of the in-vivo recombinant delivery pipeline re-architected under Dr. Ines Marchetti-Roux in November 2015 and in operation across the four commercial Morphic templates today. Six sibling units were built to the same specification between 1994 and 1999; three were retired at various dates between 2011 and 2016, two were disassembled for training use, and one, Chamber No. I, has stood in the Group's reserve bay at the Sükhbaatar campus since the 2015 re-architecture, dormant but on charter, against the eventuality of a v2 pipeline interruption. No such interruption having arisen in the four years since, the reserve charter is now closed.
The unit was crated for shipment on the twenty-third of September 2001, nine days after the Novel-Therapy Injunction, and travelled with the Group's principal apparatus through the years of the Exodus. It supported the corporation's first commercial Phenotype Renovations™ procedure at the overseas satellite site in October 2002; the first commercial client in August 2004; the interim Ulaanbaatar laboratory from September 2010; and the Sükhbaatar Square campus from October 2013. Group records indicate that Chamber No. I supported four hundred and eleven procedures across the thirteen years of its primary clinical service, and that a further seventy-four were carried out with it under the reserve schedule between November 2015 and its last documented use in February 2016. It has been dormant, cleaned, and under monthly integrity check since.
“The v1 chambers did work that no piece of apparatus of that generation had any right to do. They did it in the wrong country, then, in due course, in the right one; they did it under an injunction, and then not under an injunction; and they did it for four hundred and eleven clients whose confidence in that generation of the technology was the only reason a v2 generation was ever asked for. I have kept Chamber No. I on charter for four years past the point at which the pipeline required it, because I was not quite ready to say we were done with it. We are now.”
— Dr. Ines Marchetti-Roux, Chief Scientific Officer and Director of the Hephaestus Group
The unit itself
Chamber No. I is a single-column borosilicate cylinder, two point four metres in overall height and six hundred and forty millimetres in internal diameter, hand-blown to specification in a Cambridge workshop over the winter of 1993–94 and delivered to the laboratory in April 1994. The cylinder is closed above and below by dished stainless-steel end caps carrying the port array and the auxiliary services trunk; the caps are the fourth set fitted to the unit, the previous three having been replaced in the ordinary course of maintenance in 1998, 2011, and 2017. The glass itself is original.
Engraved on the base of the cylinder, in a hand that the Group's Cambridge records identify as that of the designer, are the three initials H.G.C. Beneath the initials, in the same hand, is the small anvil-and-crucible device with which every internal document of the Hephaestus Group is marked. Per the corporation's long-standing convention regarding the Cambridge-era partnership, the designer — one of the four founding partners — is not further identified in this notice, and the corporation will not entertain enquiries directed at establishing the identification by other means.
The observance
A short closed observance was held at the reserve bay on the eleventh of November, attended by Dr. Alastair R. Vellacott, the surviving founding partners, Dr. Marchetti-Roux, Dr. Kenji Arai, Ms. Nomin Batbayar, and the members of the Hephaestus Group whose service with the unit extended to five years or more. The observance was neither publicised nor recorded; a single reading was given, on which the corporation does not propose to elaborate. The unit's charter was signed off at the close of the observance and the unit was placed into its transport crate the same afternoon.
“It was not the practice, in Cambridge, to name apparatus. Chamber No. I was called the column in the notebooks of the period, and the column for a number of years after that, and only became No. I when there was a No. II to distinguish it from. I am glad it is going home under its Cambridge name rather than its inventory number, and I am glad it is going home at all.”
— Dr. Alastair R. Vellacott, in remarks at the observance
The loan to the Whipple Museum
The Whipple Museum of the History of Science, of Free School Lane, Cambridge, holds one of the more considered collections of twentieth-century laboratory apparatus in the United Kingdom, and was approached by the corporation in the early spring of 2019 with the proposal that Chamber No. I be received on permanent loan. Correspondence conducted over the following seven months resolved the technical, insurance, and interpretive terms of the loan; the Museum's Curator of Twentieth-Century Instruments, together with two members of its conservation staff, attended the Sükhbaatar observance to accept the unit into the Museum's care.
The corporation understands that Chamber No. I will, in due course, be displayed in the Museum's twentieth-century instruments gallery, and has, at the Museum's request, contributed a short archival note explaining what the unit did, without disclosure of the specific protocols under which it did it. The chamber will remain the property of Furnetics Unlimited Ltd. for the duration of the loan; the corporation retains no right to recall it save at the Museum's convenience, and does not anticipate exercising that right.
No change to clinical operations
Chamber No. I has carried no procedure under the current pipeline since 2016, and its removal from the standing inventory does not affect the availability, safety register, or client-facing terms of the Phenotype Renovations™ service line. The v2 partial-organic dissolution chambers presently in service across the four Morphic templates are of an unrelated architecture, are not descendants of the Cambridge design, and are not affected by this notice.
Enquiries from institutional partners, regulators, and the Museum's own visitors may be directed to the Office of the General Counsel, 15 Sükhbaatar Square, Ulaanbaatar. Enquiries seeking further identification of the designer, or seeking access to the Group's internal records concerning the unit's period of clinical service, will be acknowledged and not answered.
About Furnetics
Furnetics Unlimited Ltd. was founded in Cambridge in 1992 and has operated from its Ulaanbaatar campus since 2010. It offers four service lines — Genetic Maintain™, Phenotype Renovations™, Genotype Renovations™, and Genetic Select™ — under the oversight of an Independent Ethics Board constituted in 2014. Further information is available at furnetics.com.
— ends —